Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.

Many companies just iterate indefinitely without ever making progress toward an actual drug,” said one biotech VC on a panel ...

A local researcher and seasoned executives founded a company that will bring new medical technology to market.

Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...

The ground beneath cities is warming and deforming owing to subsurface urban heat islands. Here, I discuss questions whose answers can help to develop the cross-disciplinary knowledge needed to ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

When Hurricane Helene damaged western North Carolina in September, filling medical facilities with people who couldn't be ...

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – ...

ESSA Pharma (NASDAQ:EPIX), a biotechnology company focused on developing treatments for metastatic castration-resistant prostate cancer, saw its stock downgraded by major brokerages Oppenheimer and ...

Meet Jaipur-born businessman, a billionaire, owns pharma company in Russia, played key role in making Sputnik vaccines during COVID, his net worth is Rs.... This powerful nation knew about Israel ...

What is the best career fit for me? Take our assessment now. Finding your dream job starts with knowing what makes you the way you are. Simple Statements that relate to you. Unique Be yourself ...